The Benzodiazepine Receptor: The Pharmacology of Emotion

7Citations
Citations of this article
5Readers
Mendeley users who have this article in their library.

Abstract

Anxiety seems to be an inherent and perhaps necessary component of civilization. However, the biological basis of anxiety has always been as obscure as the definition of anxiety itself. The importance of anxiety to our mental wellbeing was noted by Freud (1933) who considered it a “nodalpoint”. As in the case of schizophrenia, there have been as many hypotheses to explain anxiety as there have been investigators with different techniques for studying it. The benzodiazepines, introduced clinically in I960, are now the most widely-used anxiolytic drugs. From the time of their introduction, it was felt that an explanation of the mode of action of benzodiazepines might shed considerable light on the basis of anxiety. The discovery, in 1977, of a specific benzodiazepine receptor, uniquely localized in the CNS, was the major turning point in this search (Squires and Braestrup, 1977; Mohler and Okada, 1977). © 1980, Canadian Neurological Sciences Federation. All rights reserved.

Cite

CITATION STYLE

APA

Robertson, H. A. (1980). The Benzodiazepine Receptor: The Pharmacology of Emotion. Canadian Journal of Neurological Sciences / Journal Canadien Des Sciences Neurologiques, 7(3), 243–245. https://doi.org/10.1017/S031716710002326X

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free